Progressive Disease With Low Survival in Adult Patients With Pulmonary Fibrosis Carrying Surfactant-Related Gene Mutations: An Observational Study.

Autor: Klay D; Department of Pulmonology, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein, The Netherlands., Grutters JC; Department of Pulmonology, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein, The Netherlands; Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: j.grutters@antoniusziekenhuis.nl., van der Vis JJ; Department of Pulmonology, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein, The Netherlands; Department of Clinical Chemistry, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein, The Netherlands., Platenburg MGJP; Department of Pulmonology, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein, The Netherlands., Kelder JC; Department of Epidemiology and Statistics, St. Antonius Hospital, Nieuwegein, The Netherlands., Tromp E; Department of Epidemiology and Statistics, St. Antonius Hospital, Nieuwegein, The Netherlands., van Moorsel CHM; Department of Pulmonology, ILD Center of Excellence, St. Antonius Hospital, Nieuwegein, The Netherlands; Division of Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands.

Publikováno v: Chest [Chest] 2023 Apr; Vol. 163 (4), pp. 870-880. Date of Electronic Publication: 2022 Nov 09.

Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases.

Autor: Moll SA; Department of Pulmonology, St. Antonius Hospital Nieuwegein, Centre for Interstitial Lung Diseases, Nieuwegein, The Netherlands., Platenburg MGJP; Department of Pulmonology, St. Antonius Hospital Nieuwegein, Centre for Interstitial Lung Diseases, Nieuwegein, The Netherlands., Platteel ACM; Department of Medical Microbiology and Immunology, St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands., Vorselaars ADM; Department of Pulmonology, St. Antonius Hospital Nieuwegein, Centre for Interstitial Lung Diseases, Nieuwegein, The Netherlands., Janssen Bonàs M; Department of Pulmonology, St. Antonius Hospital Nieuwegein, Centre for Interstitial Lung Diseases, Nieuwegein, The Netherlands., Kraaijvanger R; Department of Pulmonology, St. Antonius Hospital Nieuwegein, Centre for Interstitial Lung Diseases, Nieuwegein, The Netherlands., Roodenburg-Benschop C; Department of Pulmonology, St. Antonius Hospital Nieuwegein, Centre for Interstitial Lung Diseases, Nieuwegein, The Netherlands., Meek B; Department of Medical Microbiology and Immunology, St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands., van Moorsel CHM; Department of Pulmonology, St. Antonius Hospital Nieuwegein, Centre for Interstitial Lung Diseases, Nieuwegein, The Netherlands., Grutters JC; Department of Pulmonology, St. Antonius Hospital Nieuwegein, Centre for Interstitial Lung Diseases, Nieuwegein, The Netherlands.; Division Heart & Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands.

Publikováno v: PloS one [PLoS One] 2022 Nov 03; Vol. 17 (11), pp. e0277007. Date of Electronic Publication: 2022 Nov 03 (Print Publication: 2022).

Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease.

Autor: Moll SA; ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Post box 2500, 3435 CM Nieuwegein, The Netherlands., Platenburg MGJP; ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Post box 2500, 3435 CM Nieuwegein, The Netherlands., Platteel ACM; Department of Medical Microbiology and Immunology, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands., Vorselaars ADM; ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Post box 2500, 3435 CM Nieuwegein, The Netherlands., Janssen Bonàs M; ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Post box 2500, 3435 CM Nieuwegein, The Netherlands., Roodenburg-Benschop C; ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Post box 2500, 3435 CM Nieuwegein, The Netherlands., Meek B; Department of Medical Microbiology and Immunology, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands., van Moorsel CHM; ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Post box 2500, 3435 CM Nieuwegein, The Netherlands., Grutters JC; ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Post box 2500, 3435 CM Nieuwegein, The Netherlands.; Division Heart & Lungs, University Medical Centre Utrecht, 3435 CM Utrecht, The Netherlands.

Publikováno v: Journal of clinical medicine [J Clin Med] 2020 Sep 11; Vol. 9 (9). Date of Electronic Publication: 2020 Sep 11.

The MUC5B promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis.

Autor: Platenburg MGJP; Interstitial Lung Diseases Center of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands m.platenburg@antoniusziekenhuis.nl., Wiertz IA; Interstitial Lung Diseases Center of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands., van der Vis JJ; Interstitial Lung Diseases Center of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands.; Dept of Clinical Chemistry, ILD Center of Excellence, St Antonius Hospital, Nieuwegein, The Netherlands., Crestani B; Service de Pneumologie A, Hôpital Bichat, AP-HP, DHU FIRE, Paris, France.; Unité 1152, INSERM, Université Paris Diderot, Paris, France., Borie R; Service de Pneumologie A, Hôpital Bichat, AP-HP, DHU FIRE, Paris, France.; Unité 1152, INSERM, Université Paris Diderot, Paris, France., Dieude P; Unité 1152, INSERM, Université Paris Diderot, Paris, France.; Service de Rhumatologie, Hôpital Bichat, AP-HP, Paris, France.; Université de Paris, Université Paris Diderot, Paris, France., Kannengiesser C; Unité 1152, INSERM, Université Paris Diderot, Paris, France.; Université de Paris, Université Paris Diderot, Paris, France.; Laboratoire de Génétique, Hôpital Bichat, AP-HP, Paris, France., Burgers JA; Dept of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Grutters JC; Interstitial Lung Diseases Center of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands.; Division of Heart and Lungs, University Medical Center, Utrecht, The Netherlands., van Moorsel CHM; Interstitial Lung Diseases Center of Excellence, Dept of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands.; Division of Heart and Lungs, University Medical Center, Utrecht, The Netherlands.

Publikováno v: The European respiratory journal [Eur Respir J] 2020 Apr 30; Vol. 55 (4). Date of Electronic Publication: 2020 Apr 30 (Print Publication: 2020).